Identification of hsa-miR-106a-5p as an impact agent on promotion of multiple sclerosis using multi-step data analysis.
Samira Rahimirad, Mohammad Navaderi, Shokoofeh Alaei, Mohammad Hossein Sanati
The paper identifies hsa-miR-106a-5p as a dysregulated miRNA in MS patients, showing its potential as a biomarker for diagnosis.
Neurological Sciences · Jan 16, 2021Peer-reviewedSystems Biology